1. Japan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
CYBERDYNE Inc.

CYBERDYNE Inc.

202.00
JPY
-5.00
(-2.42%)
55.53BMarket Cap
Nov 12Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
2.62
3.27
6.22
7.76
8.04
7.95
8.33
8.72
9.99
15.32
20.62
20.74
18.35
- -
Basic EPS, GAAP
-3.95
-4.74
-3.53
-3.16
-3.13
-2.94
-0.71
-0.27
-2.31
-1.39
-6.99
-2.73
0.73
- -
Free Cash Flow per Basic Share
-4.5
-21.99
-8.06
-28.25
-5.48
-7.31
-2.88
-8.6
-10.88
-3.04
-5.09
-3.48
0.84
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.18
- -
- -
Book Value per Share
32.2
136.64
133.14
217.48
212.5
205.53
205.76
203.48
201.79
199.4
193.02
187.44
187.67
- -
Tangible Book Value per Share
31.92
136.35
132.82
217.17
212.08
205.2
205.25
203.04
191.82
187.04
182.68
178.87
178.58
- -
Basic Weighted Avg Shares
174
193
203
214
215
215
215
215
215
215
211
211
210
211
Sales/Revenue/Turnover
456
631
1,265
1,660
1,728
1,709
1,792
1,875
2,150
3,289
4,354
4,384
3,846
- -
Operating Margin (%)
-252.92
-279.77
-102.15
-42.05
-38.19
-48.57
-57.92
-37.33
-40.88
-34.84
-46.35
-21.12
-15.63
- -
Depreciation Expense
180
202
280
335
399
436
492
463
482
627
677
592
613
- -
Net Income, GAAP
-688
-916
-718
-676
-673
-632
-152
-59
-498
-298
-1,476
-577
153
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
263.74
117.4
- -
841.51
- -
- -
75.21
- -
Profit Margin (%)
-150.79
-145.09
-56.77
-40.72
-38.95
-36.98
-8.48
-3.15
-23.16
-9.06
-33.9
-13.16
3.98
- -
Working Capital
4,791
42,951
20,728
33,838
31,148
29,973
29,081
26,585
22,037
17,856
17,233
15,673
15,396
- -
LT Debt
- -
19,884
- -
- -
- -
- -
364
329
423
433
388
266
294
- -
Total Equity
5,996
27,777
27,064
46,737
45,674
44,203
44,259
43,786
43,450
41,983
40,477
39,593
39,609
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
3.83
0.27
- -
19.59
- -
- -
-0.37
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-0.72
-0.11
- -
-3.77
- -
- -
0.57
- -
Return on Common Equity (%)
- -
-5.42
-2.62
-1.83
-1.46
-1.41
-0.34
-0.13
-1.14
-0.7
-3.56
-1.44
0.39
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
159
173
- -
LT Borrowings
15
10
- -
LT Finance Leases
268
284
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
211
211
133
Market Capitalization
39,270
55,527
31,356

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
16,819
16,553
- -
Cash, Cash Equivalents & STI
15,084
14,842
- -
Accounts Receivable, Net
480
496
- -
Inventories
1,021
1,092
- -
Total Current Liabilities
1,187
1,157
- -
Payables & Accruals
- -
- -
- -
ST Debt
159
173
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.64%
-1.98%
0.04%
Free Cash Flow
22.28%
-27.31%
-124.08%
Net Income, GAAP
76.23%
182.36%
-126.52%
Sales/Revenue/Turnover
13.22%
17.69%
-12.27%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
4,384
2026
- -
- -
- -
- -
3,846
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
-2.73
2026
- -
- -
- -
- -
0.73
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.18
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Yoshiyuki Sankai
Full Time Employees
203
Sector
Health technology
Industry
Medical specialties
Address
2-2-1, Gakuen-Minami Tsukuba IB Japan 305-0818
IPO Date
Mar 26, 2014
Website
cyberdyne.jp
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
CYBERDYNE Inc. is a pioneering technology firm based in Japan, dedicated to the research, development, production, and ongoing support of advanced cybernic systems and equipment. The company's core focus revolves around Cybernics technology, a field fusing human, robot, and information systems. Central to their offerings is the Hybrid Assistive Limb (HAL), a wearable robotic suit designed for both medical applications, such as lower limb and single joint support to promote functional recovery in patients with conditions like spinal cord injury and stroke, and non-medical uses for lumbar support and broader physical augmentation. Beyond its renowned HAL exoskeletons, CYBERDYNE provides specialized Cybernics Treatment services, leveraging HAL to facilitate neuroplasticity and rehabilitate individuals. The company also extends its robotic expertise into general purpose systems, including autonomous cleaning robots and intelligent transportation robots for diverse indoor operational environments. Further innovations encompass communication support devices like Cyin for individuals with severe expressive difficulties, and Acoustic X, a high-speed light source for advanced photoacoustic imaging. Their comprehensive programs also include HAL FIT and Neuro HALFIT, focused on enhancing brain-nerve-musculoskeletal functions and overall physical capabilities. Founded in 2004 and headquartered in Tsukuba, Japan, CYBERDYNE is committed to creating value across medical, welfare, industrial, and daily life sectors, with recent financial reports indicating steady revenue from its product rentals and medical service segments. The company continues to advance its unique value proposition by integrating human intention with machine assistance, leading to breakthroughs in functional regeneration and support.

Company News

Company News APIChatGPT